2nd Quarter - Report
GLAUKOS CORPORATION for GLAUKOS CORPORATION
Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Legislation regarding FDA regulation of combination products
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Medicare/Medicaid MMM
H.R. 3514/ S. 1816 Improving Seniors Timely Access to Care Act of 2025 H.R. 2527 Early Detection of Vision Impairments for Children Act of 2025 CMS payment methodologies for OPPS/ASC
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FAHRNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.